Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|March 6, 2007
Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitorBart J Biemond, Elisabeth Perzborn, Philip W Friederich, et al.
Thrombosis and Haemostasis|February 6, 2010
Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitorMeyer Michel Samama, Jean-Luc Martinoli, Léna LeFlem, et al.
Thrombosis Research|May 1, 2016
Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatranPeter Ellinghaus, Elisabeth Perzborn, Peter Hauenschild, et al.
Thrombosis and Haemostasis|November 6, 2009
Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?Volker Laux, Elisabeth Perzborn, Stefan Heitmeier, et al.
Thrombosis and Haemostasis|May 3, 2013
Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primatesElisabeth Perzborn, András Gruber, Hanna Tinel, et al.
Journal of Medicinal Chemistry|September 16, 2005
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitorSusanne Roehrig, Alexander Straub, Jens Pohlmann, et al.
Thrombosis and Haemostasis|April 27, 2012
Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombinHelen Mani, Gabriele Rohde, Gertrud Stratmann, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosisTom J Parry, Zhihong Huang, Cailin Chen, et al.
Thrombosis Research|January 15, 2013
Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxabanRémi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, et al.
British Journal of Pharmacology|January 30, 2002
Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studiesJohannes-Peter Stasch, Cristina Alonso-Alija, Heiner Apeler, et al.
Pageof 3